Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?

被引:0
|
作者
Pagnoux, Christian [1 ]
Carette, Simon [2 ]
Khalidi, Nader A. [3 ]
Cuthberston, David [4 ]
Fortin, Paul R. [2 ,5 ]
Hoffman, Gary S. [6 ]
Langford, Carol A. [7 ]
Monach, Paul A.
Mouthon, Luc [9 ]
Seo, Philip [10 ]
Specks, Ulrich [11 ]
Ytterberg, Steven R. [11 ]
Merkel, Peter A. [8 ]
Guillevin, Loic [12 ]
The Vcrc
机构
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Univ S Florida, Tampa, FL USA
[5] Univ Toronto, Toronto, ON, Canada
[6] Cleveland Clin Found A50, Cleveland, OH USA
[7] Cleveland Clin, Cleveland, OH 44106 USA
[8] Boston Univ, Sch Med, Boston, MA 02118 USA
[9] Hop Cochin, F-75674 Paris, France
[10] Johns Hopkins Vasculitis Ctr, Baltimore, MD USA
[11] Mayo Clin, Rochester, MN USA
[12] Cochin Univ Hosp, Paris, France
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2368
引用
收藏
页码:S923 / S923
页数:1
相关论文
共 50 条
  • [21] Lymphocyte counts in patients with ANCA-associated vasculitis
    Holbro, Andreas
    Schuetz, Philipp
    Berger, Christoph
    Hess, Christoph
    Daikeler, Thomas
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (07) : 807 - 810
  • [22] A typical presentation in patients with ANCA-associated vasculitis
    Coulter, Tanya
    Conlon, Niall
    Abuzakouk, Mohamed
    Jackson, John
    Feighery, Conleth
    APMIS, 2009, 117 : 98 - 98
  • [23] IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis
    LS Jeffs
    CA Peh
    A Nelson
    PG Tan
    E Davey
    K Chappell
    GB Perkins
    PR Hurtado
    Immunologic Research, 2019, 67 : 325 - 336
  • [24] IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis
    Jeffs, L. S.
    Peh, C. A.
    Nelson, A.
    Tan, P. G.
    Davey, E.
    Chappell, K.
    Perkins, G. B.
    Hurtado, P. R.
    IMMUNOLOGIC RESEARCH, 2019, 67 (4-5) : 325 - 336
  • [25] DETERMINANTS OF RITUXIMAB PHARMACOKINETICS AND CLINICAL OUTCOMES IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Cornec, D.
    Kabat, B.
    Mills, J.
    Cheu, M.
    Hummel, A.
    Schroeder, D.
    Cascino, M.
    Brunetta, P.
    Murray, D.
    Snyder, M.
    Fervenza, F.
    Hoffman, G.
    Kallenberg, C.
    Langford, C.
    Merkel, P.
    Monach, P.
    Seo, P.
    Spiera, R.
    St Clair, W.
    Ytterberg, S.
    Stone, J.
    Barnidge, D.
    Specks, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 187 - 188
  • [26] CLINICAL SIGNIFICANCE OF URINALYSIS FINDING IN REMITTED ANCA-ASSOCIATED VASCULITIS PATIENTS
    Kinomura, Masaru
    Sada, Ken-ei
    Usui, Joichi
    Sugiyama, Hitoshi
    Makino, Hirofumi
    RHEUMATOLOGY, 2017, 56 : 128 - 128
  • [27] Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis
    Chen, Y-X.
    Zhang, W.
    Chen, X-N.
    Ni, L-Y.
    Shen, P-Y.
    Wang, W-M.
    Chen, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S5 - S10
  • [28] EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
    Luqmani, R.
    Flossmann, O.
    Jayne, D. R. W.
    Hellmich, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S118 - S118
  • [29] Cardiovascular Burden in Patients with ANCA-Associated and Non-ANCA Associated Vasculitis
    Arevalo, Ana
    Shah, Palak
    Zala, Harshvardhan
    Haddadin, Faris
    Majmundar, Monil
    Gomez, Andrea Ramirez
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 888 - 890
  • [30] DEFINING THE GUT MICROBIOME IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Najem, Catherine
    Lee, Jung-Jin
    Tanes, Ceylan
    Sreih, Antoine
    Rhee, Rennie
    Geara, Abdallah
    Li Hongzhe
    Bittinger, Kyle
    Lewis, James
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1040 - 1040